Stay updated on Tucatinib & Trastuzumab in HER2+ Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the Tucatinib & Trastuzumab in HER2+ Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tucatinib & Trastuzumab in HER2+ Solid Tumors Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    Added Revision: v3.4.3 and removed Revision: v3.4.2 from the history log.
    Difference
    0.0%
    Check dated 2026-03-06T18:16:30.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    32 days ago
    Change Detected
    Summary
    Record history now shows a new revision (v3.4.2) and removes the previous revision (v3.4.1), updating the revision sequence for this study.
    Difference
    0.0%
    Check dated 2026-02-13T13:28:34.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    The page history shows the addition of revision v3.4.1 and the removal of revision v3.4.0. This is a minor metadata update to the site's revision records and does not affect trial data or core content; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-06T09:20:51.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    The page history shows a new revision entry: Revision: v3.3.4 added and Revision: v3.3.3 removed, reflecting a minor behind-the-scenes update with no changes to study data or user-facing functionality; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-15T10:57:32.000Z thumbnail image
  7. Check
    82 days ago
    Change Detected
    Summary
    Added Contacts/Locations and Study Status sections to the study record history, reflecting updated recruitment status and site information.
    Difference
    0.2%
    Check dated 2025-12-25T02:28:15.000Z thumbnail image
  8. Check
    89 days ago
    Change Detected
    Summary
    Revision: v3.3.3 was added to the Record History and the items HHS Vulnerability Disclosure and Revision: v3.3.2 were removed from the footer.
    Difference
    0.1%
    Check dated 2025-12-17T20:27:01.000Z thumbnail image

Stay in the know with updates to Tucatinib & Trastuzumab in HER2+ Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tucatinib & Trastuzumab in HER2+ Solid Tumors Clinical Trial page.